Our Capabilities
Transpire Bio—leaders in inhalation
Our team has the unique know-how and capabilities needed to develop in-house inhaled therapeutics, as well as inhaled therapeutics for our innovative partners.
Transpire Bio—leaders in inhalation
Our team has the unique know-how and capabilities needed to develop in-house inhaled therapeutics, as well as inhaled therapeutics for our innovative partners.
Deep inhalation R&D expertise
We have a deep bench of inhalation experts. Our team has been involved with over half of the approved innovative inhaled drugs on the US market today.
Our inhalation expertise includes:
Formulation development
Delivery device development
Clinical
Manufacturing
Regulatory
Fully developed, advanced inhalation platforms
We have developed commercial scale, clinical-stage inhalation formulation technologies and delivery platforms that are fully customizable to different clinical applications.
Flexible clinical applications
Our inhalation technology platforms have wide applicability and can support small molecules, polypeptides, protein, oligoneucleotides, biologics, and vaccines.
State-of-the-art, US-based development capabilities
State-of-the-art,
US-based development capabilities
We have built and operationalized 24,000 square feet of advanced cGMP facilities to support formulation and device development, including pilot-scale manufacturing capabilities.
Specialized, high-capacity, US-based manufacturing
We have invested $60+ million to-date to build our current development and manufacturing capabilities, and are in the process of building an additional 139,000 square feet of high-volume commercial manufacturing capacity. Our end-to-end manufacturing capabilities are located in the US and will support our current and future pipeline products.
